Bellevue Life Sciences Ac...

11.60
-0.01 (-0.09%)
At close: Jan 28, 2025, 1:33 PM

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20
Cash & Equivalents 15.42K 124.50K 4.76K 62.65K
Short-Term Investments n/a n/a n/a n/a
Long-Term Investments 36.61M n/a n/a n/a
Other Long-Term Assets n/a 1.10M 700.33K 260.10K
Receivables n/a n/a n/a n/a
Inventory n/a n/a n/a n/a
Other Current Assets 7.21K n/a n/a n/a
Total Current Assets 22.63K 124.50K 4.76K 62.65K
Property-Plant & Equipment n/a n/a n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a
Total Long-Term Assets 36.61M 1.10M 700.33K 260.10K
Total Assets 36.63M 1.23M 705.09K 322.75K
Account Payables n/a 34.00K 2.85K n/a
Deferred Revenue n/a n/a n/a n/a
Short-Term Debt n/a 1.20M 400.00K 300.00K
Other Current Liabilities 1.51M 29.36K 304.36K 21.56K
Total Current Liabilities 2.04M 1.26M 707.21K 321.56K
Long-Term Debt n/a n/a n/a n/a
Other Long-Term Liabilities 2.07M n/a n/a n/a
Total Long-Term Liabilities 2.07M 1.23M n/a n/a
Total Liabilities 4.11M 1.26M 707.21K 321.56K
Total Debt n/a 1.20M 400.00K 300.00K
Common Stock 36.43M 173.00 173.00 173.00
Retained Earnings -3.91M -62.51K -27.12K -23.81K
Comprehensive Income n/a n/a n/a n/a
Shareholders Equity 32.52M -37.51K -2.12K 1.19K
Total Investments 36.61M n/a n/a n/a